Ligutan, Baby Girl .
HRN: 23-76-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/25/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
09/25/2023
10/01/2023
IVT
15mg
OD
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes